Comparison

Atriopeptin III, rat European Partner

Manufacturer GenScript
Category
Type Peptides
Specific against Rat
Amount 0.5mg
Item no. RP11203-0.5
Targets AGT
eClass 6.1 34160400
eClass 9.0 32160409
Available
Chemical Bridge
Disulfide bridge: Cys3-Cys19
Description
Atriopeptin is a 28 amino acid peptide synthesized primarily in cardiac atria. Atriopeptin acts in opposition to angiotensin II in regulating renal, hemodynamic, and endocrine function. Atriopeptin is released in response to the increased pressure and mechanical stretch of the right atrium due to blood volume overload. Atriopeptin then acts at the nephron to increase salt and water excretion, lowering blood volume and blood pressure. The effects of atriopeptin III (AP III) on in vitro prepared afferent (AA) and efferent arterioles (EA) from rat kidneys were tested in a system in which lumen diameter could be measured. AP III (10(-13)-10(-7) M) had no effect on lumen diameter of AA that were not preconstricted.
Storage
Store at -20C
Product Origin
USA

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.5mg
Available: In stock
available

Delivery expected until 6/6/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close